Abstract
Drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus surveillance.
Highlights
The Centers for Disease Control and Prevention (CDC) convened a conference on March 12–13, 2003, in Atlanta, Georgia, to discuss improving state-based surveillance of drugresistant Streptococcus pneumoniae (DRSP) and methicillin-resistant Staphylococcus aureus (MRSA)
The conference was organized by the Divisions of Healthcare Quality Promotion and Bacterial and Mycotic Diseases, National Center for Infectious Diseases, CDC
National- and statelevel epidemiologists discussed the benefits of including state-level surveillance data with appropriate antibiotic use programs designed to address the antibiotic prescribing practices of clinicians
Summary
The Centers for Disease Control and Prevention (CDC) convened a conference on March 12–13, 2003, in Atlanta, Georgia, to discuss improving state-based surveillance of drugresistant Streptococcus pneumoniae (DRSP) and methicillin-resistant Staphylococcus aureus (MRSA). The Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories, and CDC co-sponsored the conference; 120 participants from 38 states attended. The primary theme of the conference general sessions was the public health impact of DRSP and MRSA and the need for accurate surveillance data to track and monitor resistance trends.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
